Spiess PE - Search Results

1

Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.

Kirk PS, Lotan Y, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Spiess PE, van Rhijn BWG, Mertens L, Black P, Wright JL. Kirk PS, et al. Among authors: spiess pe. J Urol. 2023 May;209(5):882-889. doi: 10.1097/JU.0000000000003193. Epub 2023 Feb 16. J Urol. 2023. PMID: 36795962

2

Malignant mesothelioma of the tunica vaginalis.

Spiess PE, Tuziak T, Kassouf W, Grossman HB, Czerniak B. Spiess PE, et al. Urology. 2005 Aug;66(2):397-401. doi: 10.1016/j.urology.2005.03.012. Urology. 2005. PMID: 16040098

3

Metastatic umbilical mass from transitional cell carcinoma of the bladder.

Spiess PE, Kassouf W, Tukaram K, Roy I. Spiess PE, et al. Can J Urol. 2005 Oct;12(5):2856-8. Can J Urol. 2005. PMID: 16274525

4

Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?

Spiess PE, Kassouf W, Brown G, Highshaw R, Wang X, Do KA, Kamat AM, Czerniak B, Dinney CP, Grossman HB. Spiess PE, et al. Urology. 2006 Mar;67(3):466-71. doi: 10.1016/j.urology.2005.09.043. Urology. 2006. PMID: 16527559

5

Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.

Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Blehm KN, et al. Among authors: spiess pe. Clin Cancer Res. 2006 Aug 1;12(15):4671-7. doi: 10.1158/1078-0432.CCR-06-0407. Clin Cancer Res. 2006. PMID: 16899617

6

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

7

Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.

Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, Dinney CP, Pisters LL. Evans JG, et al. Among authors: spiess pe. J Urol. 2006 Oct;176(4 Pt 1):1463-7. doi: 10.1016/j.juro.2006.06.016. J Urol. 2006. PMID: 16952661

8

Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.

Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Spiess PE, et al. J Urol. 2007 Jan;177(1):131-8. doi: 10.1016/j.juro.2006.08.092. J Urol. 2007. PMID: 17162023

9

Review of the M.D. Anderson experience in the treatment of bladder sarcoma.

Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, Czerniak B, Kamat AM, Dinney CP, Grossman HB. Spiess PE, et al. Urol Oncol. 2007 Jan-Feb;25(1):38-45. doi: 10.1016/j.urolonc.2006.02.003. Urol Oncol. 2007. PMID: 17208137

10

Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience.

Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, Tu SM, Tannir NM, Pisters LL. Spiess PE, et al. J Urol. 2007 Apr;177(4):1330-4; discussion 1334. doi: 10.1016/j.juro.2006.11.086. J Urol. 2007. PMID: 17382725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters